MAPT and early-onset autosomal dominant Alzheimer disease: Tau protein malfunction is a core feature of a group of neurodegenerative diseases labeled ‘tauopathies’ that include, among others, Alzheimer’s disease and frontotemporal dementia, with parkinsonism linked to chromosome 17 (FTDP-17).